Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Sells 3,404 Shares of Aflac Incorporated (NYSE:AFL)

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group decreased its holdings in shares of Aflac Incorporated (NYSE:AFL) by 24.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 10,649 shares of the financial services provider’s stock after selling 3,404 shares during the period. Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group’s holdings in Aflac were worth $1,102,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in AFL. Raymond James Financial Inc. bought a new stake in shares of Aflac during the 4th quarter valued at $163,409,000. Amundi increased its position in shares of Aflac by 81.1% in the 4th quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock valued at $285,181,000 after buying an additional 1,232,683 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of Aflac by 471.4% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider’s stock valued at $67,080,000 after buying an additional 495,000 shares in the last quarter. Assenagon Asset Management S.A. increased its position in shares of Aflac by 670.9% in the 4th quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock valued at $57,572,000 after buying an additional 484,378 shares in the last quarter. Finally, World Investment Advisors LLC bought a new stake in shares of Aflac in the 3rd quarter valued at $42,290,000. Institutional investors own 67.44% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Morgan Stanley upped their price objective on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. Piper Sandler lowered their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. Evercore ISI lowered their price objective on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research report on Wednesday, December 4th. Barclays reduced their target price on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, February 7th. Finally, JPMorgan Chase & Co. upped their target price on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Aflac presently has an average rating of “Hold” and an average target price of $103.36.

Aflac Trading Down 1.5 %

Aflac stock opened at $104.67 on Thursday. The firm has a 50-day moving average of $105.24 and a 200-day moving average of $107.70. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The company has a market cap of $57.21 billion, a price-to-earnings ratio of 10.90, a P/E/G ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Insider Activity at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the sale, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 55,546 shares of company stock worth $5,863,616. Insiders own 0.90% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.